DK164941C - Gaerhybridvektor, transformeret gaercelle samt fremgangsmaade til fremstilling af vaevsplasminogenaktivitor (tpa) - Google Patents

Gaerhybridvektor, transformeret gaercelle samt fremgangsmaade til fremstilling af vaevsplasminogenaktivitor (tpa)

Info

Publication number
DK164941C
DK164941C DK551084A DK551084A DK164941C DK 164941 C DK164941 C DK 164941C DK 551084 A DK551084 A DK 551084A DK 551084 A DK551084 A DK 551084A DK 164941 C DK164941 C DK 164941C
Authority
DK
Denmark
Prior art keywords
gercelle
tpa
transformed
plasminogen activator
tissue plasminogen
Prior art date
Application number
DK551084A
Other languages
Danish (da)
English (en)
Other versions
DK551084D0 (da
DK164941B (da
DK551084A (da
Inventor
Bernd Meyhack
Albert Hinnen
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838331045A external-priority patent/GB8331045D0/en
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK551084D0 publication Critical patent/DK551084D0/da
Publication of DK551084A publication Critical patent/DK551084A/da
Publication of DK164941B publication Critical patent/DK164941B/da
Application granted granted Critical
Publication of DK164941C publication Critical patent/DK164941C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C12N15/69—Increasing the copy number of the vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/58—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi
    • C12N9/60—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi from yeast
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
DK551084A 1983-11-21 1984-11-20 Gaerhybridvektor, transformeret gaercelle samt fremgangsmaade til fremstilling af vaevsplasminogenaktivitor (tpa) DK164941C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB838331045A GB8331045D0 (en) 1983-11-21 1983-11-21 Synthesis of fibrinolytic agents by yeast
GB8331045 1983-11-21
GB848423112A GB8423112D0 (en) 1983-11-21 1984-09-13 Synthesis of fibrino lytic agents by yeast
GB8423112 1984-09-13

Publications (4)

Publication Number Publication Date
DK551084D0 DK551084D0 (da) 1984-11-20
DK551084A DK551084A (da) 1985-05-22
DK164941B DK164941B (da) 1992-09-14
DK164941C true DK164941C (da) 1993-02-01

Family

ID=26287024

Family Applications (1)

Application Number Title Priority Date Filing Date
DK551084A DK164941C (da) 1983-11-21 1984-11-20 Gaerhybridvektor, transformeret gaercelle samt fremgangsmaade til fremstilling af vaevsplasminogenaktivitor (tpa)

Country Status (17)

Country Link
EP (1) EP0143081B1 (fr)
JP (1) JPS6119489A (fr)
KR (1) KR930002889B1 (fr)
AU (1) AU595478B2 (fr)
DD (1) DD229151A5 (fr)
DE (1) DE3479520D1 (fr)
DK (1) DK164941C (fr)
ES (1) ES8609471A1 (fr)
FI (1) FI86746C (fr)
GR (1) GR80966B (fr)
HU (1) HU201115B (fr)
IE (1) IE57699B1 (fr)
IL (1) IL73568A (fr)
NO (1) NO844618L (fr)
NZ (1) NZ210266A (fr)
PH (1) PH22337A (fr)
PT (1) PT79518B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL68366A (en) * 1982-04-15 1990-08-31 Genentech Inc Process for expressing a gene encoding a protein comprising the enzymatic portion of human urokinase in a microorganism or cell culture
US7138505B1 (en) 1984-01-12 2006-11-21 Novartis Vaccines And Diagnostics, Inc. Factor VIII:C nucleic acid molecules
JPS61502655A (ja) * 1984-07-09 1986-11-20 インテグレ−テッド・ジェネティックス・インコ−ポレ−テッド 酵母クロ−ニングビヒクル
DK175327B1 (da) * 1984-10-01 2004-08-23 Integrated Genetics Inc Replicerbar ekspressionsvektor og rekombinant DNA-molekyle, som indkoder aktiv human livmodervævsplasminogen-aktivator, pattedyrscelle transformeret med vektoren og fremgangsmåde til fremstilling af aktiv human vævsplasminogen-aktivator (TPA)
JPS624233A (ja) * 1985-07-01 1987-01-10 Toyobo Co Ltd 組織性プラスミノ−ゲン活性化因子の製造法
JPS6229975A (ja) * 1985-08-01 1987-02-07 Mitsui Toatsu Chem Inc 粗ｔＰＡの精製法
GB8521496D0 (en) * 1985-08-29 1985-10-02 Ciba Geigy Ag Repressible yeast promoters
EP0216573B1 (fr) * 1985-09-18 1990-11-22 Green Cross Corporation Promoteur de levure et méthode de la production de protéines hétérologues
USH2055H1 (en) * 1985-09-20 2002-12-03 Zymogenetics, Inc. Expression of tissue-type plasminogen activator in bacteria
GB8530631D0 (en) 1985-12-12 1986-01-22 Ciba Geigy Ag Thrombin inhibitors
MY101203A (en) * 1985-12-12 1991-08-17 Ucp Gen Pharma Ag Production of thrombin iinhibitors.
US5106741A (en) * 1985-12-20 1992-04-21 The Upjohn Company Tissue plasminogen activator (TPA) analogs
US4898825A (en) * 1986-05-07 1990-02-06 Mitsui Toatsu Chemicals, Incorporated Methods for purification of single-chain and double-chain tissue plasminogen activator
ZA872534B (en) * 1986-05-08 1987-11-25 Phillips Petroleum Co Yeast production of streptokinase
PT84991B (pt) * 1986-06-06 1990-03-08 Genentech Inc Processo para a producao de actividador do plasminogenio biologicamente activo
JPS6463378A (en) * 1986-08-11 1989-03-09 Mitsui Toatsu Chemicals Separation of single stranded tpa and double standard tpa
GB8621118D0 (en) * 1986-09-01 1986-10-08 Whitbread & Co Plc Stabilised polypeptides
EP0263072B1 (fr) 1986-10-03 1994-03-23 Ciba-Geigy Ag Peptides analogues au lymphokine
PT86162B (pt) * 1986-11-21 1990-11-20 Smithkline Beecham Corp Expressao de proteina recombinante
ZA879286B (en) 1986-12-16 1988-10-26 Smith Kline Rit New plasminogen activators
US5149533A (en) * 1987-06-04 1992-09-22 Zymogenetics, Inc. Modified t-PA with kringle-/replaced by another kringle
US5089409A (en) * 1989-09-28 1992-02-18 Monsanto Company Method of increasing specific activity of t-pa
US5326700A (en) * 1990-11-06 1994-07-05 Eli Lilly And Company DNA sequences encoding t-PA derivatives with cleavable sites
SG49862A1 (en) * 1993-08-04 2002-03-19 Ucp Gen Pharma Ag High molecular weight desulphatohirudin
EP0801682B1 (fr) 1995-02-09 2001-10-24 Novartis AG Procede de production de proteines

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775622A (en) * 1982-03-08 1988-10-04 Genentech, Inc. Expression, processing and secretion of heterologous protein by yeast
IL68561A (en) * 1982-05-05 1991-01-31 Genentech Inc Preparation of polypeptide with human tissue plasminogen activator function,processes for making it,and dna and transformed cell intermediates thereof
GB2125047B (en) * 1982-08-09 1986-02-19 Ciba Geigy Ag Yeast hybrid vectors and their use for the production of polypeptides
EP0174835A1 (fr) * 1984-09-11 1986-03-19 The Upjohn Company Activateur de plasminogène tissulaire humain et combinaisons d'ADN recombinant
DK175327B1 (da) * 1984-10-01 2004-08-23 Integrated Genetics Inc Replicerbar ekspressionsvektor og rekombinant DNA-molekyle, som indkoder aktiv human livmodervævsplasminogen-aktivator, pattedyrscelle transformeret med vektoren og fremgangsmåde til fremstilling af aktiv human vævsplasminogen-aktivator (TPA)

Also Published As

Publication number Publication date
KR930002889B1 (ko) 1993-04-12
IE842965L (en) 1985-05-21
HUT36185A (en) 1985-08-28
DK551084D0 (da) 1984-11-20
AU3571984A (en) 1986-03-20
ES537828A0 (es) 1986-07-16
DK164941B (da) 1992-09-14
PT79518B (pt) 1986-12-12
EP0143081B1 (fr) 1989-08-23
IL73568A0 (en) 1985-02-28
NO844618L (no) 1985-05-22
FI844544A0 (fi) 1984-11-19
KR850003733A (ko) 1985-06-26
NZ210266A (en) 1988-11-29
AU595478B2 (en) 1990-04-05
DK551084A (da) 1985-05-22
JPS6119489A (ja) 1986-01-28
FI86746B (fi) 1992-06-30
ES8609471A1 (es) 1986-07-16
EP0143081A3 (en) 1987-01-07
IE57699B1 (en) 1993-03-10
PT79518A (en) 1984-12-01
HU201115B (en) 1990-09-28
FI844544L (fi) 1985-05-22
EP0143081A2 (fr) 1985-05-29
GR80966B (en) 1985-03-15
FI86746C (fi) 1992-10-12
IL73568A (en) 1992-07-15
DE3479520D1 (en) 1989-09-28
DD229151A5 (de) 1985-10-30
PH22337A (en) 1988-08-12

Similar Documents

Publication Publication Date Title
DK164941C (da) Gaerhybridvektor, transformeret gaercelle samt fremgangsmaade til fremstilling af vaevsplasminogenaktivitor (tpa)
US5108388B1 (en) Laser surgery method
IT8449315A0 (it) Sistema combinato di avviamento generazione e metodo
DE3882822D1 (de) Verfahren zur betriebsmittellokalisierung in rechnernetzen.
DK265785D0 (da) Radionavigationsanlaeg, isaer for skibe
DE3581937D1 (de) Verfahren zur herstellung von modulen, aufgestapelte integrierte schaltungen enthalten.
DE3481453D1 (de) Verfahren zur platzierung von elementen.
DE3485880D1 (de) Verfahren zur herstellung von halbleiteranordnungen.
ES531754A0 (es) Un metodo para estabilizar un activador de plasminogeno de tejido.
DE3486196D1 (de) Verfahren zur gewinnung und uebertragung von zaehlerdaten.
DK438884A (da) Behandlingsstation til en elektrofotografisk informationsskriver
DK409784A (da) Substituerede phenyl-alifatiske isoxaler, fremgangsmaade til fremstilling deraf samt antivirale praeparater indeholdende disse
DE3486006D1 (de) Verfahren zur herstellung von halbleiterlasern.
DE3381891D1 (de) Stamm von clostridium acetobutylleum und verfahren zur herstellung desselben.
DE3485089D1 (de) Verfahren zur herstellung von halbleitervorrichtungen.
IT8419567A0 (it) Metodo per congelare articoli in contenitori e apparecchiatura per realizzarlo.
DE3481320D1 (de) Verfahren zur herstellung von protease-inhibitoren.
IT8423765A0 (it) Procedimento per produrre 4-alcossianiline.
DE3483304D1 (de) Verfahren zur oligomerisierung von alpha-olefinen.
DE3486023D1 (de) Verfahren zur herstellung von urokinase zymogen.
DE3483624D1 (de) Verfahren zur herstellung von kornorientiertem siliziumstahl.
JPS52122184A (en) Standard dilution gas by using ph buffer solution* method and apparatus for preparation the same
IT8021449A0 (it) Apparato e metodo di sequenza fissa di comando per invertitore.
DK307384D0 (da) Ny plasminogen-aktivator og fremgangsmaade til fremstilling heraf samt thrombolytisk middel indeholdende samme
DE3482467D1 (de) Verfahren zur oligomerisierung von alpha-olefinen.

Legal Events

Date Code Title Description
PBP Patent lapsed